Is CVSGF or MRK a better dividend investment in 2026?

CVSGF currently yields 0.68% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: MRK offers higher current income.

What is the dividend yield difference between CVSGF and MRK?

CVSGF has a forward dividend yield of 0.68% ($0.11/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 2.08 percentage points.

Home › Compare › CVSGF vs MRK

CVSGF vs MRK: Dividend Comparison 2026

CVSGF yields 0.68% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CVSGF wins by $1.00M in total portfolio value· pulled ahead in Year 6

INVESTMENT

TIME HORIZON10 years

CVSGF

● Live price

0.68%

Share price

$16.50

Annual div

$0.11

5Y div CAGR

97.6%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1.06M

Annual income

$801,303.29

Full CVSGF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CVSGF vs MRK

📍 CVSGF pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CVSGF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CVSGF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CVSGF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CVSGF

Annual income on $10K today (after 15% tax)

$57.52/yr

After 10yr DRIP, annual income (after tax)

$681,107.80/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CVSGF beats the other by $672,779.39/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CVSGF + MRK for your $10,000?

CVSGF: 50%MRK: 50%

100% MRK50/50100% CVSGF

Portfolio after 10yr

$557.4K

Annual income

$405,550.72/yr

Blended yield

72.76%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CVSGF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

4.4

Piotroski

5/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CVSGF buys

MRK buys

No recent congressional trades found for CVSGF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCVSGFMRK

Forward yield	0.68%	2.76% ✓
Annual dividend / share	$0.11	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	97.6% ✓	32.7%
Portfolio after 10y	$1.06M	$56.8K ✓
Annual income after 10y	$801,303.29 ✓	$9,798.13
Total dividends collected	$1.02M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: CVSGF vs MRK ($10,000, DRIP)

Year	CVSGF Portfolio	CVSGF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1	$10,834	$133.72	$11,206	$366.19	$372.00 → MRK
2	$11,860	$267.54	$12,650	$502.35	$790.00 → MRK
3	$13,231	$540.85	$14,407	$694.19	$1.2K → MRK
4	$15,271	$1,114.27	$16,585	$967.82	$1.3K → MRK
5	$18,715	$2,375.10	$19,342	$1,363.89	$627.00 → MRK
6← crossover	$25,401	$5,375.38	$22,913	$1,947.19	+$2.5K → CVSGF
7	$40,652	$13,472.96	$27,662	$2,823.89	+$13.0K → CVSGF
8	$83,317	$39,819.90	$34,159	$4,173.35	+$49.2K → CVSGF
9	$239,866	$150,716.24	$43,337	$6,308.80	+$196.5K → CVSGF
10	$1,057,959	$801,303.29	$56,776	$9,798.13	+$1.00M → CVSGF

CVSGF vs MRK: Complete Analysis 2026

CVSGF — Stock

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail. It operates animal veterinary practices and complementary veterinary diagnostic businesses. The company also provides pet cremation and clinical waste services for veterinary practices. In addition, it operates Animed Direct, an online retail business that sells prescription and non-prescription medicines, pet foods, and other pet care products; and an online dispensary. Further, the company provides burial grounds; veterinary instrumentation supply; and property development services. It owns 472 veterinary practices, 3 laboratories, and 7 crematoria in the United Kingdom, the Netherlands, and the Republic of Ireland. CVS Group plc was founded in 1999 and is headquartered in Diss, the United Kingdom.

Full CVSGF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CVSGF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CVSGF vs SCHD CVSGF vs JEPI CVSGF vs O CVSGF vs KO CVSGF vs MAIN CVSGF vs JNJ CVSGF vs ABBV CVSGF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.